乳腺癌中的肿瘤浸润淋巴细胞：准备好迎来黄金时代了吗？ - Suppr

Suppr

超能文献

Tumor-infiltrating lymphocytes in breast cancer: ready for prime time?

作者信息

Ocaña Alberto, Diez-Gónzález Laura, Adrover Encarna, Fernández-Aramburo Antonio, Pandiella Atanasio, Amir Eitan

机构信息

Albacete University Hospital, Albacete, Spain

Albacete University Hospital, Albacete, Spain.

出版信息

J Clin Oncol. 2015 Apr 10;33(11):1298-9. doi: 10.1200/JCO.2014.59.7286. Epub 2015 Mar 9.

DOI:10.1200/JCO.2014.59.7286

PMID:25753437

Abstract

摘要

相似文献

Tumor-infiltrating lymphocytes in breast cancer: ready for prime time?

J Clin Oncol. 2015 Apr 10;33(11):1298-9. doi: 10.1200/JCO.2014.59.7286. Epub 2015 Mar 9.

Tumor-infiltrating lymphocytes in triple-negative breast cancer: a biomarker for use beyond prognosis?

J Clin Oncol. 2015 Apr 10;33(11):1297-8. doi: 10.1200/JCO.2014.59.2808. Epub 2015 Mar 9.

Host antitumor immunity plays a role in the survival of patients with newly diagnosed triple-negative breast cancer.

J Clin Oncol. 2014 Sep 20;32(27):2935-7. doi: 10.1200/JCO.2014.56.7677.

Reply to A. Ocaña et al and P.G. Tsoutsou et al.

J Clin Oncol. 2015 Apr 10;33(11):1299-300. doi: 10.1200/JCO.2014.59.9423. Epub 2015 Mar 9.

Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes.

Virchows Arch. 2017 Apr;470(4):381-389. doi: 10.1007/s00428-017-2083-5. Epub 2017 Feb 9.

Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.

Ann Surg Oncol. 2016 Jul;23(7):2242-8. doi: 10.1245/s10434-016-5173-8. Epub 2016 Mar 10.

Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers.

Hum Pathol. 2017 Jun;64:7-12. doi: 10.1016/j.humpath.2017.01.004. Epub 2017 Jan 30.

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer.

BMC Cancer. 2018 Jan 2;18(1):4. doi: 10.1186/s12885-017-3916-y.

The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC).

Breast Cancer. 2018 Jan;25(1):34-42. doi: 10.1007/s12282-017-0781-0. Epub 2017 May 9.

The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer.

Oncotarget. 2017 Feb 28;8(9):15584-15592. doi: 10.18632/oncotarget.14698.

引用本文的文献

MRI radiomics for diagnosing small BI-RADS 4 breast lesions: an interpretable model.

Quant Imaging Med Surg. 2025 Jun 6;15(6):5060-5072. doi: 10.21037/qims-24-1893. Epub 2025 May 23.

Intratumoral and peritumoral radiomics based on automated breast volume scanner for predicting human epidermal growth factor receptor 2 status.

Front Oncol. 2025 Apr 16;15:1556317. doi: 10.3389/fonc.2025.1556317. eCollection 2025.

DCE-MRI radiomics of primary breast lesions combined with ipsilateral axillary lymph nodes for predicting efficacy of NAT.

BMC Cancer. 2025 Apr 1;25(1):589. doi: 10.1186/s12885-025-14004-3.

The prognostic value of the tumor-stroma ratio compared to tumor-infiltrating lymphocytes in triple-negative breast cancer: a review.

Virchows Arch. 2025 Mar;486(3):427-444. doi: 10.1007/s00428-025-04039-z. Epub 2025 Feb 4.

Differentiation between invasive ductal carcinoma and ductal carcinoma in situ by combining intratumoral and peritumoral ultrasound radiomics.

Biomed Eng Online. 2024 Nov 21;23(1):117. doi: 10.1186/s12938-024-01315-y.

Radiomic Machine Learning in Invasive Ductal Breast Cancer: Prediction of Ki-67 Expression Level Based on Radiomics of DCE-MRI.

Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241288751. doi: 10.1177/15330338241288751.

Germinal center B-cell subgroups in the tumor microenvironment cannot be overlooked: Their involvement in prognosis, immunotherapy response, and treatment resistance in head and neck squamous carcinoma.

Heliyon. 2024 Sep 11;10(19):e37726. doi: 10.1016/j.heliyon.2024.e37726. eCollection 2024 Oct 15.

T-reg transcriptomic signatures identify response to check-point inhibitors.

Sci Rep. 2024 May 6;14(1):10396. doi: 10.1038/s41598-024-60819-8.

Development and validation of ultrasound-based radiomics model to predict germline BRCA mutations in patients with breast cancer.

Cancer Imaging. 2024 Feb 29;24(1):31. doi: 10.1186/s40644-024-00676-w.

Features from MRI texture analysis associated with survival outcomes in triple-negative breast cancer patients.

Breast Cancer. 2022 Jan;29(1):164-173. doi: 10.1007/s12282-021-01294-1. Epub 2021 Sep 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验